Abstract
The commercialization of academic science has come to be understood as economically desirable for institutions, individual researchers, and the public. Not surprisingly, commercial activity, particularly that which results from patenting, appears to be producing changes in the standards used to evaluate scientists’ performance and contributions. In this context, concerns about a gender gap in patenting activity have arisen and some have argued for the need to encourage women to seek more patents. They believe that because academic advancement is mainly dependent on productivity (Stuart and Ding in American Journal of Sociology 112:97–144, 2006; Azoulay et al. in Journal of Economic Behavior & Organization 63:599–623, 2007), differences in research output have the power to negatively impact women’s careers. Moreover, in the case of patenting activity, they claim that the gender gap also has the potential to negatively affect society. This is so because scientific and technological advancement and innovation play a crucial role in contemporary societies. Thus, women’s more limited involvement in the commercialization of science and technology can also be detrimental to innovation itself. Nevertheless, calls to encourage women to patent on grounds that such activity is likely to play a significant role in the betterment of both women’s careers and society seem to be based on two problematic assumptions: (1) that the methods to determine women’s productivity in patenting activities are an appropriate way to measure their research efforts and the impact of their work, and (2) that patenting, particularly in academia, benefits society. The purpose of this paper is to call into question these two assumptions.
Similar content being viewed by others
Notes
Of course, to the extent that number of patents is used to evaluate scientists’ careers, this would be a matter of concern. But it seems that the appropriate response in this case would be to eliminate this criterion rather than to simply accept it and encourage women to patent more.
References
Angell, M. (2000). Is academic medicine for sale? New England Journal of Medicine, 342, 1516–1518.
Angell, M. (2004). The truth about the drug companies: How they deceive us and what to do about it? New York: Random House.
Azoulay, P., Ding, W., & Stuart, T. (2007). The determinants of faculty patenting behavior: Demographics or opportunities? Journal of Economic Behavior & Organization, 63, 599–623.
Berman, E. (2008). Why did universities start patenting? Institution-building and the road to the Bayh-Dole act. Social Studies of Science, 38, 835–871.
Bethony, J. M., Cole, R. N., Guo, X., Kamhawi, S., Lightowlers, M. W., Loukas, A., et al. (2011). Vaccines to combat the neglected tropical diseases. Immunological Reviews, 239, 237–270.
Bhandari, M., Busse, J. W., Jackowski, D., Montori, V. M., Schunemann, H., Sprague, S., et al. (2004). Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized. Canadian Medical Association Journal, 170, 477–480.
Blumenthal, D., Campbell, E. G., Gokhale, M., Yucel, R., Clarridge, B., Hilgartner, S., et al. (2006). Data withholding in genetics and the other life sciences: Prevalences and predictors. Academic Medicine, 81, 137–145.
Braisher, T. L., Symonds, M. R. E., & Gemmell, N. J. (2005). Publication success in nature and science is not gender dependent. Bioessays, 27, 858–859.
Brody, B. (2006). Intellectual property and biotechnology: The US internal experience—Part I. Kennedy Institute of Ethics Journal, 16, 1–37.
Brody, H. (2007). Hooked: Ethics, the medical profession, and the pharmaceutical industry. Lanham: Rowman & Littlefield.
Burrelli, J. (2008). Thirty-three years of women in S&E faculty positions. Washington, DC: National Science Foundation.
Butcher, J. (2011). Women in science and medicine. Lancet, 377, 811–812.
Campbell, E. G., & Bendavid, E. (2003). Data-sharing and data-withholding in genetics and the life sciences: Results of a national survey of technology transfer officers. Journal of Health Care Law & Policy, 6, 241–255.
Carnes, M., Morrissey, C., & Geller, S. E. (2008). Women’s health and women’s leadership in academic medicine: Hitting the same glass ceiling? Journal of Women’s Health, 17, 1453–1462.
Ceci, S. J., & Williams, W. M. (2011). Understanding current causes of women’s underrepresentation in science. Proceedings of the National Academy of Sciences of the United States of America, 108, 3157–3162.
Cohen, J., Dibner, M. S., & Wilson, A. (2010). Development of and access to products for neglected diseases. PLoS One, 5, e10610.
Colagiuri, R., Colagiuri, S., Yach, D., & Pramming, S. (2006). The answer to diabetes prevention: Science, surgery, service delivery, or social policy? American Journal of Public Health, 96, 1562–1569.
Colyvas, J., & Powell, W. (2007). From vulnerable to venerated: The institutionalization of academic entrepreneurship in the life sciences. Research in the Sociology of Organizations, 25, 210–259.
Currat, L. J., de Francisco, A., Al-Tuwaijri, S., Ghaffar, A., & Jupp, S. (2004). 10/90 Report on health research 2003–2004. Geneva: Global Forum for Health Research.
de Melo-Martin, I., & Intemann, K. (2009). How do disclosure policies fail? Let us count the ways. FASEB Journal, 23, 1638–1642.
Ding, W. W., Murray, F., & Stuart, T. E. (2006). Gender differences in patenting in the academic life sciences. Science, 313, 665–667.
European Commission. (2009). She figures 2009: Statistics and indicators on gender equality in science. Luxembourg: Publication Office of the European Union.
Fabrizio, K. (2007). University patenting and the pace of industrial innovation. Industrial and Corporate Change, 16, 505–534.
Fabrizio, K., & Di Minin, A. (2008). Commercializing the laboratory: Faculty patenting and the open science environment. Research Policy, 37(5), 914–931.
Fox, M. (2005). Gender, family characteristics, and publication productivity among scientists. Social Studies of Science, 35(1), 131–150.
Frietsch, R., Haller, I., Funken-Vrohlings, M., & Grupp, H. (2009). Gender-specific patterns in patenting and publishing. Research Policy, 38, 590–599.
Garber, K. (2006). Biomedical patents: Broad patent faces narrow odds in court battle. Science, 311(5769), 1855–1857.
Geiger, R. L., & Sá, C. M. (2008). Tapping the riches of science: Universities and the promise of economic growth. Cambridge, MA: Harvard University Press.
Geuna, A. (2001). The changing rationale for European university research funding: Are there negative unintended consequences? Journal of Economic Issues, 35, 607–632.
Gold, E. R., Kaplan, W., Orbinski, J., Harland-Logan, S., & N-Marandi, S. (2010). Are patents impeding medical care and innovation? Plos Medicine, 7(1), e1000208.
Grushcow, J. (2004). Measuring secrecy: A cost of the patent system revealed. Journal of Legal Studies, 33(1), 59–84.
Hall, B., Jaffe, A., & Trajtenberg, M. (2005). Market value and patent citations. RAND Journal of Economics, 36, 16–38.
Hamad, B. (2010). The antibiotics market. Nature Reviews Drug Discovery, 9, 675–676.
Heckenberg, A., & Druml, C. (2010). Gender aspects in medical publication—The Wiener klinische Wochenschrift. Wiener Klinische Wochenschrift, 122, 141–145.
Heller, M. A., & Eisenberg, R. S. (1998). Can patents deter innovation? The anticommons in biomedical research. Science, 280, 698–701.
Henderson, R., Jaffe, A., & Trajtenberg, M. (1998). Universities as a source of commercial technology: A detailed analysis of university patenting, 1965–1988. Review of Economics and Statistics, 80, 119–127.
Holman, C. (2006). Clearing a path through the patent thicket. Cell, 125(4), 629–633.
Hotez, P. J., & Brown, A. S. (2009). Neglected tropical disease vaccines. Biologicals, 37, 160–164.
Hunter, L. A., & Leahey, E. (2010). Parenting and research productivity: New evidence and methods. Social Studies of Science, 40, 433–451.
Jagsi, R., Guancial, E. A., Worobey, C. C., Henault, L. E., Chang, Y. C., Starr, R., et al. (2006). The “gender gap” in authorship of academic medical literature: A 35-year perspective. New England Journal of Medicine, 355, 281–287.
Jagsi, R., Tarbell, N. J., Henault, L. E., Chang, Y. C., & Hylek, E. M. (2008). The representation of women on the editorial boards of major medical journals: A 35-year perspective. Archives of Internal Medicine, 168, 544–548.
Jensen, P. H., & Webster, E. (2011). The effects of patents on scientific inquiry. Australian Economic Review, 44, 88–94.
Kaufman, R. R., & Chevan, J. (2011). The gender gap in peer-reviewed publications by physical therapy faculty members: A productivity puzzle. Physical Therapy, 91, 122–131.
Kelly, C. D., & Jennions, M. D. (2006). The h index and career assessment by numbers. Trends in Ecology & Evolution, 21, 167–170.
Khan, S. N., Mermer, M. J., Myers, E., & Sandhu, H. S. (2008). The roles of funding source, clinical trial outcome, and quality of reporting in orthopedic surgery literature. American Journal of Orthopedics, 37, E205–E212.; Discussion E12.
Kieff, F. (2001). Facilitating scientific research: Intellectual property rights and the norms of science—A response to Rai and Eisenberg. Northwestern University Law Review, 95, 691–705.
Kleinman, D. L. (2003). Impure cultures: University biology and the world of commerce. Madison, WI: University of Wisconsin Press.
Kleinman, D., & Vallas, S. (2001). Science, capitalism, and the rise of the “knowledge worker”: The changing structure of knowledge production in the United States. Theory and Society, 30, 451–492.
Kresse, H., Belsey, M. J., & Rovini, H. (2007). The antibacterial drugs market. Nature Reviews Drug Discovery, 6, 19–20.
Krimsky, S. (2003). Science in the private interest: Has the lure of profits corrupted biomedical research? Lanham: Rowman & Littlefield.
Larsen, M. T. (2011). The implications of academic enterprise for public science: An overview of the empirical evidence. Research Policy, 40, 6–19.
Lave, R., Mirowski, P., & Randalls, S. (2010). Introduction: STS and neoliberal science. Social Studies of Science, 40, 659–675.
Leahey, E. (2006). Gender differences in productivity: Research specialization as a missing link. Gender & Society, 20, 754–780.
Lemley, M. A. (2008). Are universities patent trolls? Fordham Intellectual Property, Media & Entertainment Law Journal, 18, 611–631.
Loewenberg, S. (2009). The Bayh-Dole act: A model for promoting research translation? Molecular Oncology, 3, 91–93.
Loise, V., & Stevens, A. J. (2010). The Bayh-Dole act turns 30. Science Translational Medicine, 2, 27–52.
Long, J. S. (1992). Measures of sex-differences in scientific productivity. Social Forces, 71, 159–178.
Loscalzo, J. (2011). Can scientific quality be quantified? Circulation, 147(35), 947–950.
Macdonald, A. L. (1992). Feminine ingenuity: Women and invention in America. New York: Ballantine Books.
Mayer, S. (2006). Declaration of patent applications as financial interests: A survey of practice among authors of papers on molecular biology in nature. Journal of Medical Ethics, 32(11), 658–661.
McMillan, G. S. (2009). Gender differences in patenting activity: An examination of the US biotechnology industry. Scientometrics, 80, 683–691.
Mirowski, P. (2011). Science-mart: Privatizing American science. Cambridge, MA: Harvard University Press.
Mirowski, P., & Sent, E.-M. (2002). Science bought and sold: Essays in the economics of science. Chicago: University of Chicago Press.
Morton, M. J., & Sonnad, S. S. (2007). Women on professional society and journal editorial boards. Journal of the National Medical Association, 99, 764–771.
Mowery, D. C., & Ziedonis, A. A. (2002). Academic patent quality and quantity before and after the Bayh-Dole act in the United States. Research Policy, 31, 399–418.
Murray, F., & Graham, L. (2007). Buying science and selling science: Gender differences in the market for commercial science. Industrial and Corporate Change, 16, 657–689.
Murray, F., & Stern, S. (2007). Do formal intellectual property rights hinder the free flow of scientific knowledge? An empirical test of the anti-commons hypothesis. Journal of Economic Behavior & Organization, 63(4), 648–687.
National Science Foundation. (2007). Women, minorities, and persons with disabilities in science and engineering. Arlington, VA: National Science Foundation.
Nelson, R. R. (2004). The market economy and the scientific commons. Research Policy, 33, 455–471.
Nkansah, N., Nguyen, T., Iraninezhad, H., & Bero, L. (2009). Randomized trials assessing calcium supplementation in healthy children: Relationship between industry sponsorship and study outcomes. Public Health Nutrition, 12(10), 1931–1937.
Noskin, G. A., Rubin, R. J., Schentag, J. J., Kluytmans, J., Hedblom, E. C., Jacobson, C., et al. (2007). National trends in Staphylococcus aureus infection rates: Impact on economic burden and mortality over a 6-year period (1998–2003). Clinical Infectious Diseases, 45, 1132–1140.
Owen-Smith, J., & Powell, W. W. (2003). The expanding role of university patenting in the life sciences: Assessing the importance of experience and connectivity. Research Policy, 32, 1695–1711.
Penas, C. S., & Willett, P. (2006). Gender differences in publication and citation counts in librarianship and information science research. Journal of Information Science, 32, 480–485.
Penin, J. (2010). On the consequences of patenting university research: Lessons from a survey of French academic inventors. Industry and Innovation, 17, 445–468.
Prpic, K. (2002). Gender and productivity differentials in science. Scientometrics, 55, 27–58.
Rafferty, M. (2008). The Bayh-Dole act and university research and development. Research Policy, 37, 29–40.
Rai, A. (1999). Regulating scientific research: Intellectual property rights and the norms of science. Northwestern University Law Review, 94(1), 77–152.
Rasmussen, N. (2002). Of ‘small men’, big science and bigger business: The second world war and biomedical research in the United States. Minerva, 40, 115–146.
Reed, D. A., Enders, F., Lindor, R., McClees, M., & Lindor, K. D. (2011). Gender differences in academic productivity and leadership appointments of physicians throughout academic careers. Academic Medicine, 86, 43–47.
Rhoten, D., & Powell, W. (2007). The frontiers of intellectual property: Expanded protection versus new models of open science. Annual Review of Law and Social Science, 3, 345–373.
Ridker, P. M., & Torres, J. (2006). Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000–2005. Journal of the American Medical Association, 295, 2270–2274.
Robinson, S., Lecky, F., & Mason, S. (2010). Editorial boards: Where are all the women? European Journal of Emergency Medicine, 17, 61–62.
Rosser, S. (2009). The gender gap in patenting: Is technology transfer a feminist issue? NWSA Journal, 21, 65–84.
Sampat, B. (2006). Patenting and US academic research in the twentieth century: The world before and after Bayh-Dole. Research Policy, 35, 772–789.
Sampat, B. N. (2010). Lessons from Bayh-Dole. Nature, 468, 755–756.
Schnittker, J., & Karandinos, G. (2010). Methuselah’s medicine: Pharmaceutical innovation and mortality in the United States, 1960–2000. Social Science and Medicine, 70, 961–968.
Schrager, S., Bouwkamp, C., & Mundt, M. (2011). Gender and first authorship of papers in family medicine journals 2006–2008. Family Medicine, 43, 155–159.
Seltzer, S. E., Menard, A., Cruea, R., & Arenson, R. (2010). “Hyperscrutiny” of academic-industrial relationships: Potential for unintended consequences—A response. Journal of the American College of Radiology, 7, 39–42.
Sidhu, R., Rajashekhar, P., Lavin, V. L., Parry, J., Attwood, J., Holdcroft, A., et al. (2009). The gender imbalance in academic medicine: A study of female authorship in the United Kingdom. Journal of the Royal Society of Medicine, 102, 337–342.
Siepmann, T. (2004). The global exportation of the US Bayh-Dole act. University of Dayton Law Review, 30(2), 209–243.
Sismondo, S. (2008). Pharmaceutical company funding and its consequences: A qualitative systematic review. Contemporary Clinical Trials, 29, 109–113.
Slaughter, S., & Rhoades, G. (2004). Academic capitalism and the new economy: Markets, state, and higher education. Baltimore: Johns Hopkins University Press.
Smith, C. D., & MacFadyen, B. (2010). Industry relationships between physicians and professional medical associations: Corrupt or essential? Surgical Endoscopy, 24, 251–253.
So, A., Sampat, B., Rai, A., Cook-Deegan, R., Reichman, J., Weissman, R., et al. (2008). Is Bayh-Dole good for developing countries? Lessons from the US experience. Plos Biology, 6(10), e262.
Stephan, P. E., & El-Ganainy, A. (2007). The entrepreneurial puzzle: Explaining the gender gap. Journal of Technology Transfer, 32, 475–487.
Sterckx, S. (2011). Patenting and licensing of university research: Promoting innovation or undermining academic values? Science and Engineering Ethics, 17, 45–64.
Stuart, T., & Ding, W. (2006). The social structural determinants of academic entrepreneurship: An analysis of university scientists’ participation in commercial ventures. American Journal of Sociology, 112, 97–144.
Symonds, M. R. E., Gemmell, N. J., Braisher, T. L., Gorringe, K. L., & Elgar, M. A. (2006). Gender differences in publication output: Towards an unbiased metric of research performance. Plos One, 1(1), e127.
Thimmesh, C., & Sweet, M. (2000). Girls think of everything: Stories of ingenious inventions by women. Boston: Houghton Mifflin.
Vallas, S., & Kleinman, D. (2007). Contradiction, convergence and the knowledge economy: The confluence of academic and commercial biotechnology. Socio-Economic Review, 6, 283–311.
Van Overwalle, G. (2010). Turning patent swords into shares. Science, 330(6011), 1630–1631.
Whittington, K., & Smith-Doerr, L. (2005). Gender and commercial science: Women’s patenting in the life sciences. Journal of Technology Transfer, 30, 355–370.
Whittington, K. B., & Smith-Doerr, L. (2008). Women inventors in context: Disparities in patenting across academia and industry. Gender & Society, 22, 194–218.
Yach, D., Hawkes, C., Gould, C. L., & Hofman, K. J. (2004). The global burden of chronic diseases: Overcoming impediments to prevention and control. Journal of the American Medical Association, 291, 2616–2622.
Zhuge, Y., Kaufman, J., Simeone, D. M., Chen, H., & Velazquez, O. C. (2011). Is there still a glass ceiling for women in academic surgery? Annals of Surgery, 253, 637–643.
Zycher, B., Di Masi, J., & Milne, C. (2010). Private sector contributions to pharmaceutical science: Thirty-five summary case histories. American Journal of Therapeutics, 17, 101–120.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
de Melo-Martín, I. Patenting and the Gender Gap: Should Women Be Encouraged to Patent More?. Sci Eng Ethics 19, 491–504 (2013). https://doi.org/10.1007/s11948-011-9344-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11948-011-9344-5